Corrine Savill

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Jacquelyn Sumer, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Corrine Savill:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cullinan Therapeutics, Inc. Chief Business Officer Common Stock 240,990 $3,014,785 $12.51 19 Feb 2025 Direct
Cullinan Therapeutics, Inc. Chief Business Officer Stock Option (Right to Buy) 175,000 18 Feb 2026 Direct

Insider Reports Filed by Corrine Savill

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CGEM Cullinan Therapeutics, Inc. 18 Feb 2026 1 $0 4 Chief Business Officer 19 Feb 2026, 17:00
CGEM Cullinan Therapeutics, Inc. 19 Feb 2025 2 $0 4 Chief Business Officer 21 Feb 2025, 18:00
CGEM Cullinan Oncology, Inc. 22 Feb 2024 2 $0 4 Chief Business Officer 23 Feb 2024, 17:00
CGEM Cullinan Oncology, Inc. 01 Feb 2024 3 -$475,200 4 Chief Business Officer 02 Feb 2024, 21:35
CGEM Cullinan Oncology, Inc. 29 Jan 2024 4 -$391,600 4 Chief Business Officer 30 Jan 2024, 19:00
CGEM Cullinan Oncology, Inc. 22 Jan 2024 7 -$338,246 4 Chief Business Officer 24 Jan 2024, 17:00
CGEM Cullinan Oncology, Inc. 17 Feb 2023 2 $0 4 Chief Business Officer 21 Feb 2023, 17:57
CGEM Cullinan Oncology, Inc. 18 Jul 2022 2 -$303,593 4 Acting Chief Business Officer 21 Jul 2022, 16:30
CGEM Cullinan Oncology, Inc. 11 Jul 2022 2 -$533,304 4 Acting Chief Business Officer 12 Jul 2022, 16:14
CGEM Cullinan Oncology, Inc. 11 Feb 2022 2 $0 4 Acting Chief Business Officer 15 Feb 2022, 15:43